The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
Влияние интенсивного лечения сахарного диабета на развитие и прогрессирование отдалённых осложнений при инсулинозависимом сахарном диабете
1993-09-30
SCID: 54.1/8xbukj3z
Discuss with AI
clinical neuropathydiabetic retinopathyinsulin-dependent diabetes mellitus (IDDM)intensive diabetes therapymicroalbuminuria / albuminuria
Figures from the paper
Abstract (AI)
BACKGROUND: Long-term microvascular and neurologic complications cause major morbidity and mortality in patients with insulin-dependent diabetes mellitus (IDDM). We examined whether intensive treatment with the goal of maintaining blood glucose concentrations close to the normal range could decrease the frequency and severity of these complications. METHODS: A total of 1441 patients with IDDM--726 with no retinopathy at base line (the primary-prevention cohort) and 715 with mild retinopathy (the secondary-intervention cohort) were randomly assigned to intensive therapy administered either with an external insulin pump or by three or more daily insulin injections and guided by frequent blood glucose monitoring or to conventional therapy with one or two daily insulin injections. The patients were followed for a mean of 6.5 years, and the appearance and progression of retinopathy and other complications were assessed regularly. RESULTS: In the primary-prevention cohort, intensive therapy reduced the adjusted mean risk for the development of retinopathy by 76 percent (95 percent confidence interval, 62 to 85 percent), as compared with conventional therapy. In the secondary-intervention cohort, intensive therapy slowed the progression of retinopathy by 54 percent (95 percent confidence interval, 39 to 66 percent) and reduced the development of proliferative or severe nonproliferative retinopathy by 47 percent (95 percent confidence interval, 14 to 67 percent). In the two cohorts combined, intensive therapy reduced the occurrence of microalbuminuria (urinary albumin excretion of > or = 40 mg per 24 hours) by 39 percent (95 percent confidence interval, 21 to 52 percent), that of albuminuria (urinary albumin excretion of > or = 300 mg per 24 hours) by 54 percent (95 percent confidence interval 19 to 74 percent), and that of clinical neuropathy by 60 percent (95 percent confidence interval, 38 to 74 percent). The chief adverse event associated with intensive therapy was a two-to-threefold increase in severe hypoglycemia. CONCLUSIONS: Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Key Findings
1
Across both cohorts, intensive therapy reduced clinical neuropathy incidence by 60% (95% CI, 38–74%).
2
Across both cohorts, intensive therapy reduced occurrence of microalbuminuria (≥40 mg/24 h) by 39% (95% CI, 21–52%) and albuminuria (≥300 mg/24 h) by 54% (95% CI, 19–74%).
3
In patients with IDDM and no baseline retinopathy, intensive insulin therapy reduced adjusted mean risk of developing retinopathy by 76% (95% CI, 62–85%) versus conventional therapy.
4
In patients with mild retinopathy at baseline, intensive therapy slowed retinopathy progression by 54% (95% CI, 39–66%) and reduced development of proliferative or severe nonproliferative retinopathy by 47% (95% CI, 14–67%).
5
Intensive therapy was associated with a two- to threefold increase in severe hypoglycemia as the chief adverse event.
Research Object
Patients with insulin-dependent diabetes mellitus (IDDM) enrolled in primary-prevention and secondary-intervention cohorts
Research Subject
Effect of intensive glucose-lowering insulin therapy (versus conventional therapy) on the development and progression of long-term microvascular complications (retinopathy, nephropathy, neuropathy) and occurrence of hypoglycemia
Publication Details
Publication Date
1993-09-30
Journal
Publisher
ISSN
Cited by
24909
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by16
Bias in meta-analysis detected by a simple, graphical test1997
Standards of Medical Care in Diabetes—20132012
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association2021
Standards of Medical Care in Diabetes—20122011
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2013
Epidemiology of Diabetes and Diabetes-Related Complications2008
Hypoglycemia in Diabetes2003
Clinical Update: Cardiovascular Disease in Diabetes Mellitus2016
Nutrition Therapy Recommendations for the Management of Adults With Diabetes2013
Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study2000
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range2019
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–20182019
Diabetes Mellitus and Periodontal Diseases2006
Association of Health Literacy With Diabetes Outcomes2002
Self-Management Education for Adults With Type 2 Diabetes2002
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia2001